SOCIETAL CDMO INC (SCTL) Stock Price, Forecast & Analysis
USA - NASDAQ:SCTL - US75629F1093 - Common Stock
SCTL Key Statistics, Chart & Performance
The current stock price of SCTL is 1.1 USD. In the past month the price increased by 3.77%. In the past year, price increased by 2.8%.
SCTL Latest News, Press Relases and Analysis
SCTL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 46.62 | 970.39B | ||
| JNJ | JOHNSON & JOHNSON | 18.88 | 471.87B | ||
| MRK | MERCK & CO. INC. | 10.55 | 232.09B | ||
| PFE | PFIZER INC | 7.83 | 142.48B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.11 | 94.95B | ||
| ZTS | ZOETIS INC | 19.06 | 53.55B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.53 | 22.84B | ||
| VTRS | VIATRIS INC | 4.6 | 12.50B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.97 | 10.48B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.84 | 7.96B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 6.97B | ||
| LGND | LIGAND PHARMACEUTICALS | 27.55 | 3.94B |
Related stock screener links
About SCTL
Company Profile
Societal CDMO, Inc. is a bi-coastal CDMO with capabilities spanning pre-investigational new drug (IND) development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a focus on small molecules. The company is headquartered in Exton, Pennsylvania and currently employs 275 full-time employees. The company went IPO on 2014-03-07. The firm is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. The company is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company’s products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms and facilities to handle highly potent compounds and controlled substances.
Company Info
SOCIETAL CDMO INC
1 E. Uwchlan Ave, Suite 112
Exton PENNSYLVANIA US
Employees: 275
Phone: 17705348239
SOCIETAL CDMO INC / SCTL FAQ
Can you describe the business of SOCIETAL CDMO INC?
Societal CDMO, Inc. is a bi-coastal CDMO with capabilities spanning pre-investigational new drug (IND) development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a focus on small molecules. The company is headquartered in Exton, Pennsylvania and currently employs 275 full-time employees. The company went IPO on 2014-03-07. The firm is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. The company is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company’s products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms and facilities to handle highly potent compounds and controlled substances.
What is the current price of SCTL stock?
The current stock price of SCTL is 1.1 USD. The price increased by 0.92% in the last trading session.
Does SOCIETAL CDMO INC pay dividends?
SCTL does not pay a dividend.
What is the ChartMill technical and fundamental rating of SCTL stock?
SCTL has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting SCTL stock to perform?
10 analysts have analysed SCTL and the average price target is 1.12 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.1.
What sector and industry does SOCIETAL CDMO INC belong to?
SOCIETAL CDMO INC (SCTL) operates in the Health Care sector and the Pharmaceuticals industry.
What is the market capitalization of SCTL stock?
SOCIETAL CDMO INC (SCTL) has a market capitalization of 116.26M USD. This makes SCTL a Micro Cap stock.
SCTL Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to SCTL. When comparing the yearly performance of all stocks, SCTL is one of the better performing stocks in the market, outperforming 98.08% of all stocks.
SCTL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SCTL. SCTL may be in some trouble as it scores bad on both profitability and health.
SCTL Financial Highlights
Over the last trailing twelve months SCTL reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS increased by 40.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.64% | ||
| ROE | -22.61% | ||
| Debt/Equity | 0.01 |
SCTL Forecast & Estimates
10 analysts have analysed SCTL and the average price target is 1.12 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.1.
For the next year, analysts expect an EPS growth of 45.81% and a revenue growth 2.59% for SCTL